VF
IONS icon

Virtu Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Virtu Financial’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$401K Buy
+5,342
New +$422K 0.02% 671
2022
Q3 		– Sell
-22,794
Closed -$844K – 1950
2022
Q2 		$844K Buy
+22,794
New +$860K 0.07% 256
2021
Q2 		– Sell
-14,360
Closed -$646K – 1771
2021
Q1 		$646K Buy
+14,360
New +$801K 0.05% 392
2020
Q4 		– Sell
-17,795
Closed -$844K – 1586
2020
Q3 		$844K Buy
17,795
+11,751
+194% +$653K 0.14% 154
2020
Q2 		$356K Buy
+6,044
New +$336K 0.04% 490
2019
Q3 		– Sell
-5,439
Closed -$350K – 1605
2019
Q2 		$350K Sell
5,439
-3,602
-40% -$255K 0.02% 708
2019
Q1 		$734K Buy
+9,041
New +$583K 0.04% 404
2018
Q2 		– Sell
-15,132
Closed -$667K – 2233
2018
Q1 		$667K Buy
15,132
+7,656
+102% +$389K 0.04% 549
2017
Q4 		$376K Sell
7,476
-17,313
-70% -$949K 0.02% 1070
2017
Q3 		$1.26M Buy
+24,789
New +$1.3M 0.06% 344
2016
Q1 		– Sell
-3,314
Closed -$205K – 450
2015
Q4 		$205K Buy
+3,314
New +$179K 0.03% 337
2015
Q3 		– Sell
-5,971
Closed -$344K – 363
2015
Q2 		$344K Buy
+5,971
New +$380K 0.03% 246

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virtu Financial's IONS Position: Q1 2026 in Review

Virtu Financial opened a new position in Ionis Pharmaceuticals (IONS) in Q1 2026: 5,342 shares worth $401K. The stake represents 0.02% of the portfolio and ranks #671 among its holdings. This is a return to the name: Virtu Financial previously reported a position in IONS as recently as Q2 2022.

Virtu Financial first reported a position in IONS in Q2 2015 and has held it in 12 quarters since. The position peaked at $1.26M in Q3 2017. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Virtu Financial held 5,342 shares of Ionis Pharmaceuticals worth $401K as of Q1 2026.
  • Ionis Pharmaceuticals was a new Virtu Financial position in Q1 2026.
  • Ionis Pharmaceuticals made up 0.02% of Virtu Financial's portfolio in Q1 2026, its #671 holding.
  • Virtu Financial first reported a position in Ionis Pharmaceuticals in Q2 2015 and has held it in 12 quarters since.
  • Virtu Financial's Ionis Pharmaceuticals position peaked at $1.26M in Q3 2017.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.